Arkolith/Insider Trading/VKTX/Form 4

Mancini Marianna

Chief Operating OfficerViking Therapeutics, Inc. (VKTX) · full profile →Form 4 · filed Oct 28, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$216K
Net Open-Market Flow
-$216K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 28, 2025Sell(S)6K$35.00$216K382K
Oct 27, 2025Grant(A)11K—$0389K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-254304) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML